Research feed
Recently published diabetes studies added to Dediabetes, summarized and organized by intervention and outcome.
Sorted by publication date. Some studies may have been added to Dediabetes later.
This study evaluated the impact of Flash Glucose Monitoring (FGM) on glycaemic control in youth with Type 1 Diabetes in India, finding significant reductions in HbA1c levels compared to self-monitoring.
This study evaluated the use of insulin degludec and insulin aspart guided by a clinical decision support system for glycemic control in hospitalized patients with type 2 diabetes, finding a significant percentage of blood glucose measurements within target range.
This study evaluated the impact of continuous glucose monitoring (CGM) on glycaemic control in patients with chronic pancreatitis and insulin-treated diabetes, finding significant improvements in time in range.
This study evaluated the effects of chromium supplementation on glycemic control in patients with type 2 diabetes, finding significant improvements in HbA1c and fasting plasma glucose levels.
This study evaluated the effects of colchicine on cardiovascular risk in patients with chronic coronary artery disease and diabetes, finding mixed outcomes based on diabetes status.
This study evaluated the accuracy and feasibility of real-time continuous glucose monitoring (CGM) in early postoperative intensive care after liver transplantation.
This study evaluated the combination therapy of Dapagliflozin and Linagliptin in managing Type 2 Diabetes and hypertension, showing significant improvements in various health metrics.
This study evaluated the efficacy and safety of generic semaglutide compared to innovator semaglutide in Indian adults with type 2 diabetes inadequately controlled on metformin, finding non-inferior results.
This study investigated the effects of high-dose Vitamin D3 supplementation on insulin resistance and glycaemic control in adult males with type 2 diabetes. It found no significant differences in key metabolic outcomes between the intervention and placebo groups.
This study evaluated the effects of higher doses of semaglutide on glucose levels in type 2 diabetes patients, finding modest additional benefits at higher doses.
Latest Evidence
Build your workspace to keep track of the latest diabetes research.
